← Back to headlines
Xenon Pharmaceuticals Discloses Nasdaq-Compliant Inducement Stock Grants
Neurology-focused biotech Xenon reported granting stock awards under Nasdaq Listing Rule 5635(c)(4) to attract and retain key executive talent.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
27m ago
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
49m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
1h ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago